Jonathan E. Lim - 14 Dec 2022 Form 4 Insider Report for Erasca, Inc. (ERAS)

Role: Chairman & CEO, Director, 10%+ Owner
Signature: /s/ Ebun Garner, attorney-in-fact
Issuer symbol: ERAS
Transactions as of: 14 Dec 2022
Net transactions value: +$199,600
Form type: 4
Filing time: 15 Dec 2022, 10:53:55 UTC
Previous filing: 03 Feb 2022
Next filing: 15 Feb 2023
SEC: View on sec.gov

Key filing fact

Jonathan E. Lim filed Form 4 for Erasca, Inc. (ERAS) on 15 Dec 2022.

Key facts

This page summarizes Jonathan E. Lim's Form 4 filing for Erasca, Inc. (ERAS).
1 reported transaction and 0 derivative rows are listed below.
Filing timestamp: 15 Dec 2022, 10:53.

Change

Previous filing in this sequence was filed on 03 Feb 2022.
Current net transaction value: +$199,600.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported transactions

ERAS transaction

Common Stock

Purchase

Transaction value: $199,600
Shares: +40,000
Change %: +0.2%
Price: $4.99
Shares after: 20,196,222
Date: 14 Dec 2022
Ownership: By Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005
Footnotes: F1

ERAS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 11,899,360
Date: 14 Dec 2022
Ownership: By City Hill, LLC
Footnotes: F2

An asterisk next to the price means the reported price is likely invalid.

Explanation of Responses:

Id	Content
F1	The securities reported herein may be deemed beneficially owned by each of (i) Jonathan E. Lim, M.D. and (ii) Conyee T. Lim, M.D., who are co-trustees of the Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005.
F2	Consists of shares held directly by City Hill, LLC ("City Hill"). Jonathan E. Lim, M.D. serves as the managing partner of City Hill. Dr. Lim exercises voting and dispositive control over the securities held by City Hill and is therefore deemed to be a beneficial owner of securities owned by City Hill. Dr. Lim disclaims beneficial ownership of the reported securities held by City Hill, except to the extent of his pecuniary interest therein.

Content

The securities reported herein may be deemed beneficially owned by each of (i) Jonathan E. Lim, M.D. and (ii) Conyee T. Lim, M.D., who are co-trustees of the Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005.

Consists of shares held directly by City Hill, LLC ("City Hill"). Jonathan E. Lim, M.D. serves as the managing partner of City Hill. Dr. Lim exercises voting and dispositive control over the securities held by City Hill and is therefore deemed to be a beneficial owner of securities owned by City Hill. Dr. Lim disclaims beneficial ownership of the reported securities held by City Hill, except to the extent of his pecuniary interest therein.